Trials / Completed
CompletedNCT02079259
CVP-guided Aquapheresis for the Treatment of Acute Congestion in Heart Failure
CVP-guided Aquapheresis for the Treatment of Acute Congestion in Heart Failure - A Pilot Study to Optimize Individualized Volume Depletion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- Heinrich-Heine University, Duesseldorf · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The number of patients with acute congestion on chronic heart failure is increasing. Ultrafiltration has recently been proposed as an alternative approach for the stabilization of volume balance, especially in patients with imminent diuretic resistance. There is increasing evidence that ultrafiltration may relief cardiac congestion with lesser effects on blood pressure and activation of renin angiotensin system, respectively . However, recent studies revealed conflicting results: demonstration the superiority of ultrafiltration in comparison to diuretic treatment, and a lack of evidence of benefit, as well as an excess of adverse events with ultrafiltration. Aquapheresis with adapted ultrafiltration rate guided by central venous pressure is safer than aquaphesis with a constant ultrafiltration with comparable effectiveness
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ultrafiltration |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2014-03-05
- Last updated
- 2015-03-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02079259. Inclusion in this directory is not an endorsement.